We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An FDA advisory committee voted 10 to 1 Wednesday that a muscular dystrophy drug candidate does not have enough supporting data to be considered effective. Read More
A federal judge ruled Purdue Pharma must face most of the claims in a lawsuit filed against the drugmaker by a Washington city earlier this year. Read More